Back to top
more

Tilray Brands (TLRY)

(Delayed Data from NSDQ)

$4.88 USD

4.88
3,490,398

+0.16 (3.39%)

Updated Aug 25, 2026 03:59 PM ET

After-Market: $4.88 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 41% (101 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Tilray Brands, Inc. (TLRY) Dips More Than Broader Market: What You Should Know

by Zacks Equity Research

In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $1.25, marking a -9.42% move from the previous day.

Zacks Equity Research

Tilray Brands, Inc. (TLRY) Stock Falls Amid Market Uptick: What Investors Need to Know

by Zacks Equity Research

The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $1.37, representing a -5.52% change from its previous close.

Zacks Equity Research

Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors

by Zacks Equity Research

In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $1.03, denoting a -12.71% move from the preceding trading day.

Sweta Killa headshot

Cannabis ETFs Soar as Trump Mulls Over Marijuana Reclassification

by Sweta Killa

Cannabis ETFs like WEED, CNBS and MJ surge after Trump confirmed that his administration is weighing marijuana's move from Schedule I to Schedule III.

Sundeep Ganoria headshot

Can Cannabis Stocks Reverse Their Prolonged Downtrend?

by Sundeep Ganoria

Cannabis stocks like TLRY and GTBIF remain deep in years-long slump, but U.S. federal reform or global expansion could ignite a long-awaited rebound.

Zacks Equity Research

Aurora Cannabis Pre-Q1 Earnings Analysis: Buy, Sell or Hold the Stock?

by Zacks Equity Research

ACB's global medical cannabis momentum stays strong, but near-term regulatory headwinds might have limited Q1 revenue upside.

Sundeep Ganoria headshot

Should You Buy, Hold or Sell TLRY Stock Post Q4 Earnings Release?

by Sundeep Ganoria

Tilray posts record non-cannabis revenues in fiscal 2025, but Q4 sales slip as cannabis weakness pressures overall results.

Zacks Equity Research

Tilray Brands, Inc. (TLRY) Q4 Earnings Beat Estimates

by Zacks Equity Research

Tilray Brands (TLRY) delivered earnings and revenue surprises of +166.67% and -6.46%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?

Sundeep Ganoria headshot

Cannabis Operator CRLBF Plans California Exit: How to Play the Stock?

by Sundeep Ganoria

Cresco plans to exit California, citing tough market dynamics, as it sharpens focus on high-margin growth markets.

Zacks Equity Research

Tilray Brands, Inc. (TLRY) Stock Slides as Market Rises: Facts to Know Before You Trade

by Zacks Equity Research

Tilray Brands, Inc. (TLRY) closed at $0.74 in the latest trading session, marking a -6.34% move from the prior day.